Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Looking to Bring Anti-epileptic Drug Testing Back In-House?

Published: Thursday, February 21, 2013
Last Updated: Thursday, February 21, 2013
Bookmark and Share
ARK Diagnostics introduces Anti-epileptic Drug Monitoring assays into users laboratory.

Compatibility with most common clinical chemistry platforms, means no new equipment or specialist training is required, to introduce the ARK Diagnostics range of Anti-epileptic Drug Monitoring assays into users laboratory.

Measuring serum drug concentrations provides valuable information to aid clinical decisions about patient dose.

ARK Diagnostics immunoassays, for new generation drugs such as levetiracetam, lamotrigine, gabapentin, topiramate and zonisamide, are now available in the UK, exclusively from Alpha Laboratories.

These precise enzyme immunoassays are provided in a convenient ready-to-use format for easy automation.

Unaffected by common interfering substances such as rheumatoid factor, haemoglobin or triglycerides, these robust assays provide the sensitivity needed for clinical decisions.

With excellent correlation to traditional methods such as LC-MS/MS, HPLC and FPIA, the ARK AED assays can be run on most popular analyzers, including the Cobas c501 and Beckman AU640, enabling fast turn-around times.

Anti-epileptic drugs (AEDs) are often candidates for therapeutic drug monitoring and individualization of a dose is essential in epilepsy therapy.

However, identification of the optimal dose, on clinical grounds alone, can be a challenge, as AED treatment is prophylactic and occurrence of seizures sporadic.

Monitoring of serum concentrations helps optimize long-term seizure control and prevent toxicity.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Quick, Early Test For Ebola Could Prevent Epidemics
Researchers from Princeton University are collaborating with U.S. government labs to develop a more rapid, accurate and inexpensive test for the Ebola virus with the aim of identifying infections before carriers become symptomatic and contagious.
From Super to Ultra-Resolution Microscopy
A new method pushes the frontier in imaging resolution, with the potential to distinguish individual features in single molecules.
Cancer Research UK joins forces with U.S. 'Cancer Moonshot'
Cancer Research UK and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice President Joe Biden’s Cancer Moonshot.
Assessing the Effectiveness of Genome-Editing Technologies
Researchers have developed a cost-effective and rapid method for assessing edits generated by CRISPR-Cas9 and other genome-editing technologies.
Measuring the Abundance of Extremely Rare Mutations
Researchers from Rutgers University demonstrate the use of multiplex real-time PCR assays to measure the abundance of extremely rare mutations associated with cancer.
Harnessing Helpful Microbes
Seeking to further harness microbes’ many uses, the federal government has launched the National Microbiome Initiative (NMI) to “foster the integrated study of microbiomes across different ecosystems.”

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!